Literature DB >> 11927501

Allergies and risk of non-Hodgkin's lymphoma by subtype.

Nathaniel C Briggs1, Robert S Levine, Edward A Brann.   

Abstract

To investigate the relation between allergy and risk for non-Hodgkin's lymphoma (NHL), data were analyzed from the Selected Cancers Study. Cases (n = 952) were men ages 32-60 years diagnosed with NHL from 1984 to 1988 and identified by eight population-based United States cancer registries. Controls (n = 1691) were recruited by random-digit telephone dialing and frequency matched to cases by age and geographic region of cancer registry. Logistic regression was used to calculate odds ratios and 95% confidence intervals adjusted for age, cancer registry, education, and race/ethnicity. There was no evidence that a general history of allergy was significantly associated with either overall NHL risk (odds ratio: 1.0; 95% confidence interval: 0.8-1.2) or risk for major NHL subtypes (follicular, diffuse, small cell lymphocytic, and immunoblastic). Similarly, no significant associations were observed for the most commonly reported specific allergies, including those to plants, dust, food, animals, and medications. Significant NHL subtype-specific associations were found for allergies to insects (immunoblastic) and chemicals (diffuse and small cell lymphocytic). However, these allergies were reported by relatively few study participants, and the associations may have been because of chance. In conclusion, we found little evidence that either a general history of allergy or commonly reported specific allergies are associated with NHL.

Entities:  

Mesh:

Year:  2002        PMID: 11927501

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

Review 1.  Atopy and Specific Cancer Sites: a Review of Epidemiological Studies.

Authors:  Yubao Cui; Andrew W Hill
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

2.  Primary EBV infection and hypersensitivity to mosquito bites: a case report.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Sofia Karastrati; Athanasios Tragiannidis; Nikolaos Gompakis; Maria Hatzistilianou
Journal:  Virol Sin       Date:  2016-12       Impact factor: 4.327

3.  Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.

Authors:  Eva Erber; Unhee Lim; Gertraud Maskarinec; Laurence N Kolonel
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

4.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

5.  Exploring risk factors for follicular lymphoma.

Authors:  Alexander J Ambinder; Pareen J Shenoy; Neha Malik; Alison Maggioncalda; Loretta J Nastoupil; Christopher R Flowers
Journal:  Adv Hematol       Date:  2012-09-18

6.  Allergic conditions are not associated with the risk of non-Hodgkin's lymphoma or Hodgkin's lymphoma: a systematic review and meta-analysis.

Authors:  Jia Yang; Hong'en Xu; Xiaodong Liang; Shiliang Lv; Baihua Lin; Yongshi Jia
Journal:  Onco Targets Ther       Date:  2017-04-18       Impact factor: 4.147

7.  Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.

Authors:  Helen H McDuffie; Punam Pahwa; Chandima P Karunanayake; John J Spinelli; James A Dosman
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.